Sirt1 Activation by Post-ischemic Treatment With Lumbrokinase Protects Against Myocardial Ischemia-Reperfusion Injury

Lumbrokinase is used as an oral supplement to support and maintain healthy cardiovascular function, and to treat cardiovascular diseases in clinical for more than 10 years. Up until now, the mechanism of the cardioprotective effects of post-ischemic treatment with lumbrokinase has remained unclear....

Celý popis

Uloženo v:
Podrobná bibliografie
Vydáno v:Front Pharmacol
Hlavní autoři: Wang, Yi-Hsin, Li, Shun-An, Huang, Chao-Hsin, Su, Hsing-Hui, Chen, Yi-Hung, Chang, Jinghua T., Huang, Shiang-Suo
Médium: Artigo
Jazyk:Inglês
Vydáno: Frontiers Media S.A. 2018
Témata:
Pharmacology
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC6013847/
https://ncbi.nlm.nih.gov/pubmed/29962953
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3389/fphar.2018.00636
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky